REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 15th, 2017 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • New York
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of November 3, 2016, between the Company and the Purchaser (the “Purchase Agreement”).
STRATEGIC COLLABORATION AGREEMENT between NESTEC LTD. and AIMMUNE THERAPEUTICS, INC.Strategic Collaboration Agreement • March 15th, 2017 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • New York
This STRATEGIC COLLABORATION AGREEMENT (this “Agreement”) is made as of November 3, 2016, by and between NESTEC LTD., a limited company organized and existing under the laws of Switzerland, having an office located at Avenue Nestlé 55, 1800 Vevey, Switzerland (“NHSc”), and Aimmune Therapeutics, Inc., a corporation incorporated and existing under the laws of the State of Delaware, having an office located at 8000 Marina Boulevard, Suite 300, Brisbane, CA 94005, USA (“Aimmune”). NHSc and Aimmune are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
AIMMUNE THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 15th, 2017 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (“Agreement”) is made as of November 3, 2016 (the “Effective Date”), between Aimmune Therapeutics, Inc., a Delaware corporation (the “Company”), and Nestle Health Science US Holdings, Inc., a Delaware corporation (the “Purchaser”).
Nestle Health Science US Holdings, Inc. Stamford, CT 06902Standstill Agreement • March 15th, 2017 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • New York
In connection with the acquisition of Common Stock, par value $0.0001 per share (the “Common Stock”), of Aimmune Therapeutics, Inc., a Delaware corporation (the “Company”), by Nestle Health Science US Holdings, Inc., a Delaware corporation (the “Purchaser”), pursuant to the Securities Purchase Agreement, dated as of November 3, 2016, between the Company and the Purchaser (the “Purchase Agreement”), the Purchaser hereby delivers this letter agreement (this “Standstill Agreement”) to the Company in accordance with the terms Purchase Agreement. Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to it in the Purchase Agreement.
